The abstracts address the latest research addressing clinical innovation, care delivery, health equity, clinical trial diversity, measuring patient and caregiver experience, provider efficiency, clinical outcomes, quality care, and safety in oncology.
Nashville, September 15, 2022 – OneOncology, the national platform for leading independent oncology practices, announced today that physician researchers affiliated with OneOncology partner practices will have 15 abstracts presented at the upcoming ASCO Quality Care Symposium September 30 through October 1.
Tennessee Oncology researchers will have 9 abstracts presented while 3 abstracts presented include Astera Cancer Care, 2 abstracts presented include researchers from West Cancer Center and Research Institute, and 1 abstract includes researchers from The Center for Cancer and Blood Disorders in Fort Worth, Texas.
The abstracts address the latest research addressing clinical innovation, care delivery, health equity, clinical trial diversity, measuring patient and caregiver experience, provider efficiency, clinical outcomes, quality care, and safety in oncology.
“These abstracts evidence some of the most important research advancing equity, quality and care delivery and affordability in cancer care today,” said Davey Daniel, MD, Chief Medical Officer, OneOncology. “I’m excited to see how the research presented at the Quality Care Symposium will impact cancer care, and just as excited to discuss it with physician colleagues from across OneOncology.”
For a full listing of the abstracts, click here.
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More